Clinical Trials Browser

Phase 2 × NIH × Monophenol Monooxygenase × Clear all

NCT00001685 2008-03-04

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Phase 2 Completed

Melanoma, Neoplasm Metastasis, Neoplasms